Cheap, safe, and readily accessible preventative measures that modulate severe disease outcomes are desperately needed.
A recent pilot study published in the journal Prostaglandins, Leukotrienes and Essential Fatty Acids, has provided the first bits of evidence that individuals with higher levels of omega-3 in their blood may potentially be at a reduced risk of dying from the coronavirus disease 2019 (COVID-19). The research was conducted by the Fatty Acid Research Institute (FARI) in collaboration with Cedars-Sinai Medical Center in both Los Angeles and Orange County, California.
While there is a literature that hypothesizes Omega-3 fatty acids potentially providing a benefit to patients with COVID-19, no published peer-reviewed studies have been conducted to support it.
"Asher et al have demonstrated that a low Omega-3 Index might be a powerful predictor for death from COVID-19,” Clemens von Schacky, a cardiology researcher said.
Investigators behind the study analyzed blood samples and clinical outcomes of 100 patients who were admitted to a hospital with a confirmed case of COVID-19. The participants were separated into 4 groups according to their O3I, with 25% in each quartile. The blood was examined at OmegaQuant Analytics for Omega-3 Index (O3I, red blood cell membrane EPA+DHA levels).
Findings showed that in age-and-sex adjusted regression analyses, the participants in the 3 lower quartiles (p=0.07) were 75% more likely to die when compared to those who were in the highest quartile (O3I >5.7%). This means that those with a lower O3I (<5.7%) had a 4 times higher relative risk of death.
"While not meeting standard statistical significance thresholds, this pilot study - along with multiple lines of evidence regarding the anti-inflammatory effects of EPA and DHA - strongly suggests that these nutritionally available marine fatty acids may help reduce risk for adverse outcomes in COVID-19 patients. Larger studies are clearly needed to confirm these preliminary findings," Arash Asher, lead author on this study said.
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.